Background
Methods
Cohorts
Definition of functional avidity
In vitro viral replication inhibition assay
Statistical Analyses
Results
HIV-1-specific T cell responses targeting conserved regions are associated with lower viral loads
Identification of individual beneficial OLP sequences in clade B and C infection
OLP # | Protein | Sub-unit | OLP clade B consensus sequence | Median viral load in OLP responders | Median viral load in OLP non-responders | Protective Ratio (PR)* | p-value |
---|---|---|---|---|---|---|---|
3 | Gag | p17 | EKIRLRPGGKKKYKLKHI | 22947 | 39014 |
1.053
| 0.037 |
6 | Gag | p17 | ASRELERFAVNPGLL | 15380 | 43189 |
1.107
| 0.001 |
7 | Gag | p17 | ERFAVNPGLLETSEGCR | 25939 | 38974 |
1.040
| 0.049 |
10 | Gag | p17 | QLQPSLQTGSEELRSLY | 16285 | 37237 |
1.085
| 0.031 |
12 | Gag | p17 | SLYNTVATLYCVHQRIEV | 23855 | 37113 |
1.044
| 0.037 |
23 | Gag | p24 | AFSPEVIPMFSALSEGA | 22947 | 37113 |
1.048
| 0.036 |
31 | Gag | p24 | IAPGQMREPRGSDIA | 3563 | 35483 |
1.281
| 0.028 |
34 | Gag | p24 | STLQEQIGWMTNNPPIPV | 6127 | 37360 |
1.207
| 0.002 |
48 | Gag | p24 | ACQGVGGPGHKARVLAEA | 12975 | 35755 |
1.107
| 0.041 |
60 | Gag | p15 | GKIWPSHKGRPGNFLQSR | 16266 | 36434 |
1.083
| 0.044 |
75 | Nef | - | WLEAQEEEEVGFPVRPQV | 13407 | 37360 |
1.108
| 0.026 |
76 | Nef | - | EVGFPVRPQVPLRPMTYK | 59618 | 29855 | 0.937 | 0.001 |
84 | Nef | - | NYTPGPGIRYPLTFGWCF | 55402 | 30538 | 0.945 | 0.006 |
85 | Nef | - | RYPLTFGWCFKLVPV | 69890 | 29903 | 0.924 | 0.002 |
90 | Nef | - | SLHGMDDPEKEVLVWKF | 89687 | 32650 | 0.911 | 0.042 |
159 | Pol | Pro | KMIGGIGGFIKVRQYDQI | 14736 | 36434 |
1.094
| 0.020 |
160 | Pol | Pro | FIKVRQYDQILIEICGHK | 3682 | 35755 |
1.277
| 0.031 |
161 | Pol | Pro | QILIEICGHKAIGTVLV | 9117 | 35483 |
1.149
| 0.050 |
163 | Pol | Pro | LVGPTPVNIIGRNLLTQI | 25965 | 45637 |
1.055
| 0.007 |
171 | Pol | RT | LVEICTEMEKEGKISKI | 1865 | 35483 |
1.391
| 0.014 |
181 | Pol | RT | LDVGDAYFSVPLDKDFRK | 65858 | 32871 | 0.937 | 0.041 |
195 | Pol | RT | LRWGFTTPDKKHQKEPPF | 5624 | 37113 |
1.219
| 0.006 |
196 | Pol | RT | DKKHQKEPPFLWMGYELH | 10103 | 35483 |
1.136
| 0.044 |
210 | Pol | RT | EIQKQGQGQWTYQIY | 18155 | 35483 |
1.068
| 0.045 |
222 | Pol | RT | PPLVKLWYQLEKEPIVGA | 412599 | 34640 | 0.808 | 0.030 |
230 | Pol | RT | IHLALQDSGLEVNIV | 85102 | 34117 | 0.919 | 0.030 |
237 | Pol | RT | VYLAWVPAHKGIGGNEQV | 85102 | 34117 | 0.919 | 0.029 |
240 | Pol | RT | SAGIRKVLFLDGIDKA | 116902 | 32761 | 0.891 | 0.019 |
269 | Pol | Int | TKELQKQITKIQNFRVYY | 6629 | 35755 |
1.192
| 0.030 |
270 | Pol | Int | TKIQNFRVYYRDSRDPLW | 18171 | 37360 |
1.073
| 0.019 |
271 | Pol | Int | YYRDSRDPLWKGPAKLLW | 25939 | 35755 |
1.032
| 0.043 |
276 | Pol | Int | KIIRDYGKQMAGDDCVA | 6629 | 35755 |
1.192
| 0.021 |
279 | Vpr | - | GPQREPYNEWTLELLEEL | 60222 | 32650 | 0.944 | 0.042 |
307 | Env | Gp120 | DLNNNTNTTSSSGEKMEK | 179419 | 34117 | 0.863 | 0.044 |
311 | Env | Gp120 | IRDKVQKEYALFYKLDVV | 179419 | 32871 | 0.860 | 0.008 |
314 | Env | Gp120 | YRLISCNTSVITQACPKV | 58206 | 31273 | 0.943 | 0.008 |
315 | Env | Gp120 | SVITQACPKVSFEPIPIH | 61011 | 32871 | 0.944 | 0.034 |
320 | Env | Gp120 | TNVSTVQCTHGIRPVV | 341587 | 34640 | 0.820 | 0.034 |
355 | Env | Gp120 | VAPTKAKRRVVQREKRAV | 161602 | 34117 | 0.870 | 0.042 |
399 | Env | Gp41 | VIEVVQRACRAILHIPRR | 388089 | 34640 | 0.812 | 0.026 |
405 | Vif | - | VKHHMYISGKAKGWFYRH | 16458 | 37237 |
1.084
| 0.021 |
406 | Vif | - | GKAKGWFYRHHYESTHPR | 16458 | 37237 |
1.084
| 0.022 |
424 | Vif | - | TKLTEDRWNKPQKTKGHR | 10319 | 36434 |
1.137
| 0.014 |
OLP # | Protein | Sub-unit | OLP clade C consensus sequence | Median viral load in OLP responders | Median viral load in OLP non-responders | Protective Ratio (PR)* | p-value | Q-value |
---|---|---|---|---|---|---|---|---|
3 | Gag | p17 | EKIRLRPGGKKHYMLKHL | 18,700 | 45,100 |
1.09
| 0.0002 | 0.0006 |
6 | Gag | p17 | ASRELERFALNPGLL | 6,570 | 44,100 |
1.22
| 0.0000 | 0.0000 |
7 | Gag | p17 | ERFALNPGLLETSEGCK | 5,270 | 43,900 |
1.25
| 0.0000 | 0.0000 |
22 | Gag | p24 | WVKVIEEKAFSPEVIPMF | 8,360 | 42,850 |
1.18
| 0.0000 | 0.0000 |
25 | Gag | p24 | GATPQDLNTMLNTVGGH | 24,450 | 45,200 |
1.06
| 0.0021 | 0.0263 |
26 | Gag | p24 | NTMLNTVGGHQAAMQMLK | 5,310 | 39,600 |
1.23
| 0.0061 | 0.0766 |
27 | Gag | p24 | GGHQAAMQMLKDTINEEA | 9,715 | 42,100 |
1.16
| 0.0015 | 0.0170 |
29 | Gag | p24 | AAEWDRLHPVHAGPIA | 19,700 | 40,900 |
1.07
| 0.0045 | 0.0544 |
31 | Gag | p24 | IAPGQMREPRGSDIA | 6,480 | 38,950 |
1.20
| 0.0146 | 0.1478 |
33 | Gag | p24 | SDIAGTTSTLQEQIAWM | 11,650 | 40,900 |
1.13
| 0.0025 | 0.0318 |
37 | Gag | p24 | WIILGLNKIVRMYSPVSI | 9,360 | 44,100 |
1.17
| 0.0004 | 0.0018 |
39 | Gag | p24 | SILDIKQGPKEPFRDYV | 2,630 | 38,250 |
1.34
| 0.0182 | 0.1838 |
41 | Gag | p24 | YVDRFFKTLRAEQATQDV | 22,150 | 44,100 |
1.07
| 0.0020 | 0.0263 |
42 | Gag | p24 | LRAEQATQDVKNWMTDTL | 16,480 | 40,900 |
1.09
| 0.0078 | 0.0935 |
55 | Gag | p15 | HIARNCRAPRKKGCWK | 7,550 | 39,700 |
1.19
| 0.0092 | 0.1047 |
59 | Gag | p15 | RQANFLGKIWPSHKGR | 9,840 | 42,200 |
1.16
| 0.0046 | 0.0539 |
60 | Gag | p15 | GKIWPSHKGRPGNFLQSR | 6,130 | 39,700 |
1.21
| 0.0066 | 0.0799 |
63 | Gag | p15 | TAPPAESFRFEETTPAPK | 6,040 | 38,950 |
1.21
| 0.0093 | 0.1020 |
116 | Tat | Tat | TKGLGISYGRKKRRQRRS | 109,000 | 36,700 | 0.91 | 0.0033 | 0.0410 |
178 | Pol | RT | FWEVQLGIPHPAGLKKKK | 258,000 | 37,300 | 0.84 | 0.0033 | 0.0384 |
181 | Pol | RT | LDVGDAYFSVPLDEDFRK | 7,100 | 38,950 |
1.19
| 0.0186 | 0.1832 |
190 | Pol | RT | RAQNPEIVIYQYMDDLYV | 84,900 | 34,700 | 0.92 | 0.0043 | 0.0555 |
199 | Pol | RT | TVQPIQLPEKDSWTVNDI | 6,700 | 38,300 |
1.20
| 0.0198 | 0.1926 |
216 | Pol | RT | QKIAMESIVIWGKTPKFR | 18,150 | 43,000 |
1.09
| 0.0026 | 0.0317 |
239 | Pol | RT | QVDKLVSSGIRKVLFL | 373,200 | 37,700 | 0.82 | 0.0205 | 0.1937 |
253 | Pol | Int | PAETGQETAYFILKLAGR | 92,800 | 35,400 | 0.92 | 0.0082 | 0.0954 |
265 | Pol | Int | AVFIHNFKRKGGIGGYSA | 63,650 | 33,800 | 0.94 | 0.0178 | 0.1826 |
283 | Vpr | - | GLGQYIYETYGDTWTGV | 78,000 | 35,600 | 0.93 | 0.0126 | 0.1302 |
284 | Vpr | - | ETYGDTWTGVEALIRIL | 85,050 | 35,200 | 0.92 | 0.0099 | 0.1034 |
312 | Env | Gp120 | YALFYRLDIVPLNENNSSEY | 270,000 | 37,700 | 0.84 | 0.0208 | 0.1915 |
365 | Env | Gp41 | GIKQLQTRVLAIERYLK | 151,000 | 34,700 | 0.88 | 0.0001 | 0.0002 |
393 | Env | Gp41 | LLGRSSLRGLQRGWEALKYL | 750,000 | 37,450 | 0.78 | 0.0007 | 0.0041 |
417 | Vif | - | CFADSAIRKAILGHIV | 1,110 | 38,200 |
1.50
| 0.0178 | 0.1891 |
Increased breadth of responses against beneficial OLP is associated with decreasing viral loads, independent of Gag-specificity or the presence of protective HLA class I alleles
PR-values are mediated by individuals with broad HLA heterogeneity
A) Beneficial OLP (PR > 1) | ||||
---|---|---|---|---|
OLP | Protein | PR | Removed HLA allele(s) abolishing statistical significance1 | Alleles over-represented in the OLP responder group2 |
3 | Gag | 1.09 | A30, B42, C17 | A30, B08, A03, A74, C17, A43, B42, B07 |
6 | Gag | 1.22 |
B15
| B49, B82, C14 |
7 | Gag | 1.25 | - | B42, C17, B49, A30 |
22 | Gag | 1.18 | B57, C07 | B57, A74, B45, C07, C16, B13 |
25 | Gag | 1.06 | A30, B15, C04, C07 | B42, C17, B81, B39, A01, C12, C18, A30, B67 |
26 | Gag | 1.23 | A02, A23, A68, B07, B14, B58, C07, C08 | C03, B15, A68 |
27 | Gag | 1.16 | B15, C07 | B15, A68, C03, C08 |
29 | Gag | 1.07 | A68, B15, B58, C02, C03, C06, C12 | B35, B39, C12, B40, B07, C04 |
31 | Gag | 1.2 | A02, A11, A23, A29, A32, A34, A68, B07, | B13, A29, C06, A11 |
B13, B15, B42, B44, B58, C04, C06, C07, C17 | ||||
33 | Gag | 1.13 | A02, A23, B44, B57, B58, C07 | B58, B57, A02, C07, C03, A68 |
37 | Gag | 1.17 | A30, B42, B58, C17 | C18, B42, C17, A01, B81 |
39 | Gag | 1.34 | A02, A03, A23, A29, A30, A68, A74, B08, B15, | A02 |
B18, B42, B45, B53, B57, B58, C02, C03, C06, | ||||
C07, C08, C16, C17 | ||||
41 | Gag | 1.07 |
A23, C06
| C03, B14, A68, C08, B15 |
42 | Gag | 1.09 | A23, A30, B08, B15, B42, B53, B58, C03, C04, C07 | B53, C03 |
55 | Gag | 1.19 | A02, A24, A29, A30, B07, B15, B39, B42, B44, | B42, B08, C17 |
B58, C02, C06, C07, C17 | ||||
59 | Gag | 1.16 | A02, A30, B08, B42, B44, B58, C04, C07, C17 | A02, B13, A29 |
60 | Gag | 1.21 | A02, A30, B42, B58, C06, C07, C17 | A02, B41, C07, C17 |
63 | Gag | 1.21 | A02, A23, A29, A30, A68, B08, B15, B44, B58, | A23 |
C02, C03, C06, C07 | ||||
181 | Pol | 1.19 | A01, A23, A29, A30, A34, A68, A74, B14, B15, | B57, C18 |
B18, B35, B44, B45, B57, B58, C02, C03, C04, | ||||
C06, C07, C08, C16 | ||||
199 | Pol | 1.2 | A02, A03, A23, A24, A26, A30, A31, A34, A36, A66, A68, | B53, A23, C04 |
A80, B08, B13, B15, B18, B35, B40, B41, B42, B44, B45, | ||||
B49, B50, B51, B53, B57, B58, B81, C01, C02, C03, C04, | ||||
C05, C06, C07, C08, C15, C16, C17
| ||||
216 | Pol | 1.09 | A02, A30, B58, C07, C17 | B53, B58, C07, B57 |
417 | Vif | 1.5 | A03, A23, A30, A34, A36, A68, B08, B14, B15, | B14, C08, A36 |
B44, B53, B58, C03, C04, C06, C08 | ||||
B) Non-beneficial OLP (PR < 1)
| ||||
116 | Tat | 0.91 | A02, A34, B15, C04 | B15, C02 |
178 | Pol | 0.84 | A03, A68, B15, B58, C04, C06, C07 | A68, C06, B58, B82, A03 |
190 | Pol | 0.92 | A03, A30, A66, B18, B42, B45, B58, C06, C07 | A02, B18, B35, C05, C16, B45, A80, C12, B67, B39 |
239 | Pol | 0.82 | - | C05, A03 |
253 | Pol | 0.92 | A03, A68, B15, B39, B42, B44, B58, C02, C04, C06, C08, | A68, C03, B15, B07, C15, B41 |
C17, C18 | ||||
265 | Pol | 0.94 | A02, A03, A23, A24, A26, A29, A30, A31, A33, | B15, C02, A43, A74 |
A34, A66, A68, B07, B08, B14, B15, B27, B40, B41, B42, | ||||
B44, B53, B54, B55, B57, B81, C01, C02, C04, C06, C07, | ||||
C12, C17, C18
| ||||
283 | Vpr | 0.93 | A02, A03, A23, A30, A66, A68, A74, B07, B14, B18, B39, | A68, C03, B07, C17, B41 |
B41, B42, B45, B57, C02, C04, C07, C08, C15, C17
| ||||
284 | Vpr | 0.92 | A03, A23, A30, A66, A68, A74, B07, B14, B18, B39, B42, | A68, C03 |
B45, B57, C07, C08, C15, C17
| ||||
312 | Env | 0.84 | - | B08, C07 |
365 | Env | 0.88 | B58, C06 | C06, B58, A43, B45, C16, A66 |
393 | Env | 0.78 | A30, B58, C06 | A31, C06, B45 |
Effects of T cell specificity on in vivo viral load are at least as strong as those associated with host HLA genetics
OLP variables only (Lima, clade B) | OLP variables only (Durban, clade C) | ||||
---|---|---|---|---|---|
change viral load (co-efficient) * | p-value | change viral load (co-efficient) * | p-value | ||
Beneficial
|
Beneficial
| ||||
OLP.6 | -0.4591 | 0.0008 | OLP.7 | -0.6256 | 0 |
OLP.31 | -1.4055 | 0.0002 | OLP.21 | -0.6663 | 0 |
OLP.171 | -2.5981 | 0 | OLP.22 | -0.4926 | 0.0006 |
OLP.276 | -1.127 | 0.0007 | OLP.25 | -0.2822 | 0.0002 |
OLP.27 | -0.4719 | 0.0053 | |||
Non-beneficial
| OLP.33 | -0.3396 | 0.0024 | ||
OLP.76 | 0.2486 | 0.0067 | OLP.398 | -1.8179 | 0.0027 |
OLP.306 | 3.2968 | 0.0001 | OLP.417 | -1.6535 | 0.0008 |
OLP.411 | 1.3329 | 0.012 | |||
Non-beneficial
| |||||
OLP.38 | 0.9045 | 0.0022 | |||
OLP.84 | 0.1947 | 0.0091 | |||
OLP.116 | 0.6156 | 0.0039 | |||
OLP.183 | 0.661 | 0.0013 | |||
OLP.224 | 0.2508 | 0.0036 | |||
OLP.265 | 0.5782 | 0 | |||
OLP.365 | 0.4911 | 0.0009 | |||
OLP.393 | 1.2624 | 0.0013 | |||
HLA variables only (Lima, clade B)
|
HLA variables only (Durban, clade C)
| ||||
Non-beneficial
|
Beneficial
| ||||
HLA-C0401 | 0.35652 | 0.00024 | HLA-A74 | -0.3553 | 0.0025 |
HLA-B13 | -0.6443 | 0.0004 | |||
HLA-B57 | -0.5195 | 0.0007 | |||
HLA-B81 | -0.3619 | 0.0015 | |||
HLA-C12 | -0.6544 | 0.0001 | |||
Non-beneficial
| |||||
HLA.B.15 | 0.2506 | 0.0012 | |||
HLA.B.18 | 0.5521 | 0.0005 | |||
HLA.C.6 | 0.3958 | 0 | |||
HLA and OLP variables together (Lima)
|
HLA and OLP variables together (Durban)
| ||||
Beneficial
|
Beneficial
| ||||
OLP.6 | -0.5792 | 0 | OLP.6 | -0.4798 | 0.0023 |
OLP.31 | -1.1607 | 0.0005 | OLP.7 | -0.4528 | 0.0015 |
OLP.171 | -2.7948 | 0 | OLP.27 | -0.4676 | 0.0049 |
OLP.276 | -0.9609 | 0.0011 | OLP.59 | -0.4196 | 0.0115 |
OLP.417 | -1.387 | 0.0041 | |||
Non-beneficial
|
Non-beneficial
| ||||
OLP.2 | 0.3945 | 0.018 | OLP.148 | 2.5215 | 0.0029 |
OLP.237 | 0.7211 | 0.0035 | OLP.183 | 0.6108 | 0.0023 |
OLP.288 | 1.5537 | 0.0016 | OLP.393 | 1.1442 | 0.0023 |
OLP.311 | 0.7197 | 0.0091 | |||
OLP.411 | 1.5306 | 0.0024 |
Beneficial
| ||
HLA-A74 | -0.3744 | 0.0007 | |||
Beneficial
| HLA-B57 | -0.4887 | 0.0007 | ||
HLA-B1502 | -1.4688 | 0.0164 | HLA-B81 | -0.3859 | 0.0004 |
HLA-C12 | -0.6003 | 0.0002 | |||
Non-beneficial
|
Non-beneficial
| ||||
HLA-B0801 | 0.66 | 0.0049 | HLA-B15 | 0.2797 | 0.0001 |
HLA-C0401 | 0.2894 | 0.0006 | HLA-B18 | 0.5316 | 0.0003 |
HLA-B49 | 0.9713 | 0.0007 |